NCT07159204

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

The Paclitaxel Polymer Micellar Based Combined Immunotherapy for the Posterior Line Treatment of Advanced Bile Tract Cancer

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen

Conditions

• Biliary Tract Cancer (BTC)

Interventions

Type	Name	Description
DRUG	Paclitaxel polymer micelle immunocombination	Paclitaxel polymer micelle immunocombination

Timeline

• Start date: 2023-01-01
• Primary completion: 2025-12-31
• Completion: 2026-07-01
• First posted: 2025-09-08
• Last updated: 2025-09-08

Locations

1 site across 1 country: China